Skip to content
Open access

Exploring the protective potential of remote ischemic conditioning-induced miRNAs in stroke.

Aug 2026 · Neuroscience · 0 citations · 87 references
Medicine

TL;DR

Investigation of RIC-induced miRNAs in immortalized human brain microvascular endothelial cells exposed to inflammatory conditions in vitro suggests that miR-16-5p and miR-144-3p may modulate endothelial pathways involved in cell death, inflammatory signaling, and vascular remodeling during the response to stroke.

Abstract

Remote ischemic conditioning (RIC) is a non-invasive strategy that mitigates ischemic injury, partly through circulating microRNAs. Emerging evidence suggests that miRNAs may modulate angiogenesis, which is essential for post-stroke recovery. This study investigated the effect of four RIC-induced miRNAs (RIC-miRNAs), miR-16-5p, miR-144-3p, miR-182-5p, and miR-451a, in immortalized human brain microvascular endothelial cells (IM-HBMECs) exposed to inflammatory conditions in vitro. Transcriptomic and in silico analysis were used to identify target genes of RIC-miRNAs. Two angiogenesis-related genes, SLIT2 and TEK, were validated in vitro as functional targets of miR-16-5p and miR-144-3p, respectively. Functional enrichment analysis further linked the RIC-miRNA-associated targets to the regulation of apoptotic processes, cytokine production, and sprouting angiogenesis. These findings suggest that miR-16-5p and miR-144-3p may modulate endothelial pathways involved in cell death, inflammatory signaling, and vascular remodeling during the response to stroke.

Read PDF

Similar papers

Open access Sep 2026

EXPRESS: Longitudinal Circulating miRNA Profiling Identifies Pharmacodynamic Biomarkers of Remote Ischemic Conditioning in Acute Ischemic Stroke: A Translational Sub-Study of the Randomized TRICS-9 Trial.

These findings identify miR-143, miR-150, let-7a, and miR-181b as candidate pharmacodynamic biomarkers of RIC biological activity and highlight the need for external validation in larger outcome-linked cohorts.

Rohan Mahesh Patil, Susanna Diamanti, Simone Beretta et al. · 0 citations
Review Aug 2026

Clinical significance of lncRNA-miRNA axes in ischemic stroke: Diagnostic value, prognostic relevance, and therapeutic potential.

Ischemic stroke and subsequent reperfusion injury are major causes of mortality and long-term neurological disability, driven by complex mechanisms of excitotoxicity, oxidative stress, neuroinflammation, endothelial dysfunction, and blood-brain barrier disruption. Increasing evidence indicates that long non-coding RNA...

Amr A. El-Sehrawy, I. Sapaev, O. Nematov et al. · 0 citations
Open access Aug 2026

miR-92a Agomir protects against ischemic stroke by suppressing oxidative stress, inflammation, excitotoxicity, and p53-mediated apoptosis.

Significant reductions in neurological deficit, infarction volume, edema, and BBB permeability were observed in the miR-92a Agomir+MCAO group compared to the MCAO group, providing a compelling rationale for evaluating delayed administration strategies in future translational studies.

Mahmoud Ramdan, Hosein Shahsavarani, S. Khaksar et al. · 0 citations
Open access Sep 2026

Therapeutic effects of miR-495-3p inhibition and exercise in a transient middle cerebral artery occlusion rat model.

It is suggested that combined exercise and miR-495-3p inhibition synergistically promote neuroprotection after tMCAo by suppressing ER stress-mediated signaling, attenuating excessive autophagy, and reducing apoptosis.

Eunjae Jang, J. Yoo, Hee Yu et al. · 0 citations
Open access Aug 2026

LncRNA HOTAIR/miR-9-5p/FOXP1 axis modulates cerebral ischemia-reperfusion injury via NLRP3 inflammasome activation

Functional experiments revealed that silencing miR-9–5p protected against cerebral ischemia/reperfusion injury and suppressed NLRP3 inflammasome activation following IS, suggesting that its blockade could be a potential therapeutic strategy for ischemic brain injury.

Tingting Liu, Xiao-Song Zhu, Fengjuan Zhuo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.